Botulism in critical care: A case study in wound botulism

American Journal of Critical Care

Volumn 10, Issue 3, 2001, Pages 172-180

  Baymiller, Shirley ^a  

^a Madera Community Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM ANTISERUM; DIAMORPHINE; NARCOTIC AGENT;

ADULT; ARTICLE; BOTULISM; CASE REPORT; CLASSIFICATION; HUMAN; MALE; PATIENT CARE; SUBSTANCE ABUSE;

ADULT; BOTULINUM ANTITOXIN; BOTULISM; HEROIN; HUMANS; MALE; NARCOTICS; PATIENT CARE TEAM; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0035350137     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2001.10.3.172     Document Type: Article

References (29)

1. Beaty HN. Botulism. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's Principles of Internal Medicine. 11th ed. New York, NY: McGraw-Hill Co; 1987:561-563.
2. Schwartz DA, Geyer SJ. Clostridial infections. In: Connor DH, Chandler FW, Schwartz DA, Manz HJ, Lack EE, eds. Pathology of Infectious Disease. Vol 1. Stamford, Conn: Appleton & Lange; 1997;529-531.
3. Murray PR, Baron EJ, Pfaller MA, et al. Manual of Clinical Microbiology. 7th ed. Washington, DC: American Society for Microbiology; 1999:658-659.
4. Hatheway CL. Clostridium botulinum. In: Gorbach SL, Barrett JG, Blacklow NR, eds. Infectious Diseases. Philadelphia, Pa: WB Saunders Co; 1982:1583-1585.
5. Bretz SW. Botulism? Watch your wounds. Lifeline [newsletter of the American College of Emergency Physicians, State Chapter of California Inc, Manhattan Beach, Calif]. March 2000;3:9-10.
6. Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiologic review. Ann Intern Med. 1998;129:221-228.
7. MacDonald KL, Rutherford GW, Friedman SM, et al. Botulism and botulism-like illness in chronic drug abusers. Ann Intern Med. 1985;102:616-618.
8. Passaro DJ, Werner SB, McGee J, MacKenzie WR, Vugia DJ. Wound botulism associated with black tar heroin among injecting drug users. JAMA. 1998;279:859-863.
9. Anderson MW, Sharma K, Feeney CM. Wound botulism associated with black tar heroin. Acad Emerg Med. 1997;4:805-809.
10. Werner SB, Passaro D, McGee J, Schechter R, Vugia DJ. Wound botulism in California, 1951-1998: recent epidemic in heroin injectors. Clin Infect Dis. 2000;31:1018-1024.
11. Maselli RA, Ellis W, Mandler RN, et al. Cluster of wound botulism in California: clinical, electrophysiologic, and pathologic study. Muscle Nerve. 1997;20:1284-1295.
12. Hiersemenzel LD, Jermann M, Waespe W. Descending paralysis caused by wound botulism: a case report [in German]. Nervenarzt. 2000;71:130-133.
13. Bamberger J, Terplan M. Wound botulism associated with black tar heroin. JAMA. 1998;280:1479-1480.
14. Maselli RA, Bakshi N. AAEM case report 16: botulism. American Association of Electrodiagnostic Medicine. Muscle Nerve. 2000;23:1137-1144.
15. Grand'Maison F. Methods of testing neuromuscular transmission in the intensive care unit. Can J Neurol Sci. 1998;25:S36-S39.
16. Luce JM. Neuromuscular diseases leading to respiratory failure. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care. 2nd ed. New York, NY: McGraw-Hill Co; 1998:995-996.
17. Cherington M. Clinical spectrum of botulism. Muscle Nerve. 1998;21:701-710.
18. Luce JM. Neuromuscular diseases leading to respiratory failure. In: Hall JB, Schmidt GA, Wood LH, eds. Principles of Critical Care. 2nd ed. New York, NY: McGraw-Hill Co; 1998:999-1000.
19. Engel AG. Myasthenia gravis and other disorders of neuromuscular transmission. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's Principles of Internal Medicine. 11th ed. New York, NY: McGraw-Hill Co; 1987:2079-2082.
20. Wallace JF. Disorders caused by venoms, bites, and stings. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's Principles of Internal Medicine. 11th ed. New York, NY: McGraw-Hill Co; 1987:831-836.
21. Harnisch JP. Diphtheria. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's Principles of Internal Medicine. 11th ed. New York, NY: McGraw-Hill Co; 1987:550-554.
22. Ray CG. Enteroviruses and reoviruses. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's Principles of Internal Medicine. 11th ed. New York, NY: McGraw-Hill Co; 1987:703-705.
23. Chow AW. Life-threatening infections of the head, neck, and upper respiratory tract. In: Hall JB, Schmidt GA, Wood LDH, eds. Principles of Critical Care. 2nd ed. New York, NY: McGraw-Hill Co; 1998:887-890.
24. Jablecki CK. Electrodiagnostic evaluation of patients with myasthenia gravis and related disorders. Neurol Clin. 1985;3:557-572.
25. Kim J. Botulism. Available at: http://www.emedicine.com/emerg/ topic64.htm. Last revised January 20, 2001. Accessed February 27, 2001.
26. Centers for Disease Control and Prevention, Division of Bacterial and Mycotic Diseases. Botulism. Available at: www.cdc.gov/ncidod/dbmd/ diseaseinfo/botulism_t.htm. Accessed May 2000.
27. Botulism antitoxin bivalent (equine) types A and B [package insert]. New York, NY: Connaught Laboratories Ltd; 1997.
28. Davis LE, Johnson JK, Bicknell JM, Levy H, McEvoy KM. Human type A botulism and treatment with 3,4-diaminopyridine. Electromyogr Clin Neurophysiol. 1992;32:379-383.
29. Carpenito L. Handbook of Nursing Diagnosis. 6th ed. Philadelphia, Pa: Lippincott; 1995.